CN110693848B - Vitamin A microcapsule preparation without antioxidant and preparation method thereof - Google Patents

Vitamin A microcapsule preparation without antioxidant and preparation method thereof Download PDF

Info

Publication number
CN110693848B
CN110693848B CN201911026965.7A CN201911026965A CN110693848B CN 110693848 B CN110693848 B CN 110693848B CN 201911026965 A CN201911026965 A CN 201911026965A CN 110693848 B CN110693848 B CN 110693848B
Authority
CN
China
Prior art keywords
vitamin
preparation
parts
sodium
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911026965.7A
Other languages
Chinese (zh)
Other versions
CN110693848A (en
Inventor
任翔
徐玉涛
田中乐
吴文忠
陈剑彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innobio Corp ltd
Original Assignee
Innobio Corp ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innobio Corp ltd filed Critical Innobio Corp ltd
Priority to CN201911026965.7A priority Critical patent/CN110693848B/en
Publication of CN110693848A publication Critical patent/CN110693848A/en
Application granted granted Critical
Publication of CN110693848B publication Critical patent/CN110693848B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The preparation method comprises the steps of raw material preparation, water phase preparation, oil phase preparation, emulsion preparation, spray drying and the like, wherein the raw materials comprise the following components in parts by mass: 50-70 parts of vitamin A, 5-25 parts of sodium starch octenyl succinate, 5-20 parts of Arabic gum, 1-5 parts of vitamin E polyethylene glycol succinate, 0.1-2 parts of acidity regulator, 0.1-1 part of glucose oxidase and 0-1.5 parts of anticaking agent. The invention adopts microencapsulation technology to embed vitamin A, and obtains vitamin A microcapsule powder with no antioxidant, high oil loading, high embedding rate, high bioavailability and high stability by spray drying.

Description

Vitamin A microcapsule preparation without antioxidant and preparation method thereof
Technical Field
The invention belongs to the technical field of microcapsules, and particularly relates to a preparation method of an antioxidant-free high-bioavailability high-stability vitamin A microcapsule preparation.
Background
Vitamin a was the first discovery and is also an extremely important, highly deficient, fat-soluble vitamin essential for maintaining normal metabolism and function in humans. Vitamin a is not a single compound but a series of retinol derivatives including retinol, retinal, retinoic acid, retinol acetate, retinol palmitate and the like.
Vitamin a belongs to fat-soluble vitamins, and can be dissolved in most organic solvents to different degrees, but is not dissolved in water. Vitamin a and its derivatives are readily oxidized and isomerized, especially when exposed to light (especially uv), oxygen, reactive metals, and high temperature environments, which can accelerate such oxidative destruction. But generally the cooking process does not cause too much damage to the vitamin a in the food. Under ideal conditions, such as low temperature freezing, the retinoid remains stable in serum, tissue or crystalline form for a long period of time. Retinal is relatively stable to base under anaerobic conditions, but is unstable in acid and can undergo dehydrogenation or rearrangement of double bonds. During the rancidity process, the vitamin A and carotene contained in the oil can be seriously damaged.
Therefore, many enterprises, scientific research institutions, and the like research and develop steady-state preparations of vitamin a, and it is desired to make vitamin a more stable.
CN201010101199.9 discloses a method for preparing a continuous stable vitamin A microcapsule, which comprises the steps of continuously adding vitamin A crystals and an antioxidant into a crystallization melter in proportion under the protection of nitrogen to prepare antioxidant-containing vitamin A molten oil; then the melted oil is sent into a supergravity rotating packed bed emulsifier with a liquid distributor by a pump, and simultaneously the aqueous solution containing the modified starch capable of being gelatinized is sent into the supergravity rotating packed bed emulsifier by the pump after being deoxidized, and vitamin A emulsion is obtained at an outlet; continuously atomizing the emulsion, spraying the emulsion into a cooled starch bed for granulation, and then carrying out fluidized drying and gelation treatment in a fluidized bed with nitrogen as a drying medium to obtain the stable vitamin A microcapsule. The present invention has the advantages of continuous production, good embedding effect and high product storing stability.
CN201110142580.4 discloses a preparation method of a vitamin A microcapsule nutrition enhancer for beverages, which mainly adopts sodium caseinate as a main wall material to embed VA palmitate, and adopts micromolecular maltodextrin and white granulated sugar to fill, and mainly emphasizes the oxygen-free production process, the filling of protective gas and the stability of products.
CN201710637373.3 discloses a fat-soluble nutrient microcapsule and a preparation method thereof, the preparation method of the fat-soluble nutrient microcapsule comprises emulsification and granulation processes, wherein the emulsification is performed in a cavitation emulsifier, and the preparation method can reduce the loss of nutrient active substances of the fat-soluble nutrient microcapsule and has high stability.
CN201811312455.1 discloses octenyl succinic acid starch ester, fat-soluble nutrient microcapsules, a preparation method and application thereof, wherein the preparation method of the octenyl succinic acid starch ester comprises the following steps: and carrying out esterification reaction on gelatinized starch and octenyl succinic anhydride in the cavitation emulsification process to obtain the octenyl succinic acid starch ester. The preparation method promotes and strengthens esterification reaction through a cavitation emulsification process, so that starch and octenyl succinic anhydride in a gelatinized state are remarkably substituted in a crystalline region and an amorphous region of the starch due to aggravation of molecular collision, and the esterification rate of the prepared octenyl succinic acid starch ester is further improved, thereby greatly improving the emulsification performance. The method is rapid and efficient, a hydrolysis step is not needed after esterification, the problems that molecular chains are damaged to different degrees due to hydrolysis, the chain length and the content of amylose are obviously reduced, and further the density of the formed film of the octenyl succinic acid starch ester is reduced, and the formed film is easy to absorb moisture, crisp and heat-conducting are solved, and the application performance of the method is improved.
CN 109452467A discloses a vitamin A microcapsule and a preparation method and application thereof, wherein ascorbic acid palmitate and carnosic acid are used as an antioxidant after choline and/or choline derivatives are pretreated, and unexpected synergistic effect is achieved among the components on the stability of vitamin A in feed or feed premix. It is also found that the vitamin A can maintain the optimal stability when the pH value is between 6.0 and 7.5, therefore, the invention can provide the optimal storage environment for the vitamin A by controlling the pH value of the vitamin A emulsion to be between 6.0 and 7.5 in the preparation process of the vitamin A microcapsule.
There are also many prior art studies that disclose microencapsulation of vitamin A, but these prior art techniques have relied on antioxidants to improve the stability of vitamin A. Also, although vitamin a stability after microencapsulation is improved, no prior art discloses data relating to its bioavailability. Embedding stability is the goal of our pursuit, but whether excessive embedding will affect vitamin A metabolism in vivo is also a concern.
Disclosure of Invention
The present invention aims to provide a vitamin microcapsule formulation stably embedded and having excellent release metabolism characteristics, and it is expected to realize stabilization treatment of the formulation by means of component optimization instead of using an antioxidant. Therefore, the invention firstly provides a preparation method of an antioxidant-free vitamin A microcapsule preparation, which comprises the following steps:
(1) preparing a raw material, wherein the raw material comprises the following components in parts by mass:
Figure BDA0002248962390000021
Figure BDA0002248962390000031
(2) sequentially dispersing modified starch and Arabic gum in water at 60-80 deg.C, stirring to dissolve completely, and cooling to 30-40 deg.C;
(3) adding an acidity regulator into the system obtained in the step (2), controlling the pH value to be 6-8, uniformly stirring, and adding glucose oxidase to obtain a water phase;
(4) adding vitamin E polyethylene glycol succinate into vitamin A, heating to melt at 60-80 deg.C, stirring, mixing, and cooling to 30-40 deg.C to obtain oil phase;
(5) slowly adding the oil phase into the water phase, and stirring at 30-40 ℃ until the oil phase and the water phase are uniformly mixed;
(6) shearing and emulsifying the mixture obtained in the step (5) for 0.5-1h, and then homogenizing for 2 times at 40-70MPa to obtain emulsion;
(7) and (3) spray drying the emulsion prepared in the step (6): the air inlet temperature is 80-210 ℃, and the air outlet temperature is 70-120 ℃; the product is sieved and then is uniformly mixed with an anticaking agent.
The invention adopts a microencapsulation process to embed the vitamin A, and obtains a vitamin A microcapsule powder product without antioxidant, with high oil loading, high embedding rate, high bioavailability and high stability through specific material combination and preparation process. Can be widely applied to the fields of feed, dietary supplement, daily chemical, medicine and the like.
Detailed Description
The invention provides a high-bioavailability high-vitamin A microcapsule preparation which realizes high stability independent of an antioxidant. The selection and combination of raw materials and the operation scheme adapted to the raw materials are the core technical means for realizing the technical effect of the invention. In the preparation method of the microcapsule preparation product, the raw materials comprise, by mass, 50-70 parts of vitamin A, 5-25 parts of modified starch, 5-20 parts of Arabic gum, 1-5 parts of vitamin E succinic acid polyethylene glycol ester, 0.1-1 part of glucose oxidase, 0.1-2 parts of acidity regulator and 0-1.5 parts of anticaking agent.
The vitamin a in the feed is typically crystalline and is selected from vitamin a acetate, vitamin a palmitate or mixtures thereof.
The modified starch in the raw material is selected from one or a mixture of more of sodium starch octenylsuccinate, acetylated distarch, carboxyl starch and phosphorylated starch. Sodium starch octenylsuccinate and phosphorylated starches are preferred.
The acidity regulator in the raw material is selected from one or a mixture of more of sodium bicarbonate, sodium hydroxide, sodium carbonate, calcium hydroxide and potassium hydroxide. Preferably selected from sodium bicarbonate, calcium hydroxide and sodium hydroxide.
The anticaking agent in the starting material is selected from the group consisting of silica, calcium silicate and tricalcium phosphate.
It will be readily understood that the above preferred technical features may be combined to constitute a preferred embodiment of the invention, and as demonstrated in the examples, the interaction of sodium starch octenyl succinate and gum arabic with polyethylene glycol vitamin E succinate may result in a product of high entrapment rate, high stability and high bioavailability as described in the present invention.
The following non-limiting examples further illustrate the technical solutions and effects of the present invention, and should not be construed as limiting the present invention in any way. Unless otherwise specified, all percentages in this specification mean mass percentages.
Example 1
409g of water is weighed into a 1000mL beaker, the water temperature is 62 ℃, 125g of sodium starch octenyl succinate and 100g of Arabic gum are added into the beaker, the mixture is stirred until the starch sodium octenyl succinate and the Arabic gum are completely dissolved, and the temperature is reduced to 35 ℃ for standby. Adding 6g of sodium bicarbonate into the water phase, controlling the pH value to be 6.8-7.1, and then adding 4g of glucose oxidase. Mixing 7.5g of vitamin E succinic acid polyethylene glycol ester and 252.5g of vitamin A acetic ester, melting in a water bath at 75 ℃, uniformly stirring, and cooling to 35 ℃ to obtain an oil phase. Slowly pouring the oil phase into the water phase, shearing and emulsifying at 35 deg.C for 0.5h, homogenizing at 40MPa for 2 times, and spray drying at air inlet temperature of 170 deg.C and air outlet temperature of 84 deg.C. Sieving, and adding silicon dioxide to obtain vitamin A acetate microcapsule powder, which is recorded as sample 1.
Example 2
1000g of water are weighed into a 2000mL beaker, the water temperature is 65 ℃, 200g of sodium starch octenyl succinate and 150g of Arabic gum are added into the beaker, the mixture is stirred until the starch sodium octenyl succinate and the Arabic gum are completely dissolved, and the temperature is reduced to 38 ℃ for standby. Adding 5g of calcium hydroxide into the water phase, controlling the pH value to be 6.9-7.5, and then adding 10g of glucose oxidase. Mixing 20g of vitamin E succinic acid polyethylene glycol ester and 605g of vitamin A acetic ester, melting in a water bath at 80 ℃, uniformly stirring, and cooling to 38 ℃ to obtain an oil phase. Slowly pouring the oil phase into the water phase, shearing and emulsifying at 38 deg.C for 0.5h, homogenizing at 55MPa for 2 times, and spray drying at air inlet temperature of 180 deg.C and air outlet temperature of 90 deg.C. Sieving, and adding silicon dioxide to obtain vitamin A acetate microcapsule powder, which is recorded as sample 2.
Example 3
2000g of water are weighed into a 3000mL beaker, the water temperature is 75 ℃, 240g of phosphorylated starch and 260g of acacia gum are added, the mixture is stirred until the phosphorylated starch and the acacia gum are completely dissolved, and the temperature is reduced to 40 ℃ for standby. Adding 4g of sodium hydroxide into the water phase, controlling the pH value to be 7.0-7.3, and then adding 16g of glucose oxidase. Mixing 60g of vitamin E succinic acid polyethylene glycol ester and 1400g of vitamin A palmitate, putting into a water bath with the temperature of 69 ℃ for melting, stirring uniformly, and cooling to 40 ℃ to obtain an oil phase. Slowly pouring the oil phase into the water phase, shearing and emulsifying at 40 ℃ for 1h, homogenizing at 50MPa for 2 times, and then performing spray drying, wherein the air inlet temperature is 175 ℃ and the air outlet temperature is 87 ℃. Sieving, adding silicon dioxide to obtain vitamin A acetate microcapsule powder, and recording as sample 3.
Example 4
Product performance evaluations were performed on sample 1, sample 2, and sample 3, with the results shown in table 1:
TABLE 1
Name (R) Appearance of the product Smell of nourishing Embedding rate Bulk density Particle size Reconstitution property
Sample 1 Orange yellow powder Inherent smell 99.2% 0.43g/ml Sieving with 40 mesh sieve at a rate of not less than 95% Emulsion homogeneity
Sample 2 Orange powder Inherent smell 98.9% 0.40g/ml Sieving with 40 mesh sieve at a rate of not less than 95% Emulsion homogeneity
Sample 3 Orange powder Inherent smell 99.3% 0.38g/ml Sieving with 40 mesh sieve at a rate of not less than 95% Emulsion homogeneity
The results show that the vitamin A microcapsule powder obtained by the process disclosed by the patent has high product embedding rate, good reconstitution property and appropriate bulk density and granularity, and the property indexes show that the product has excellent characteristics and can be widely applied to the fields of feeds, dietary supplements, daily chemicals, medicines and the like.
Example 5
Sample 1, sample 2 and sample 3 were placed in an accelerated oven at 40 ℃ and 75% humidity for three months for product stability evaluation, with the results shown in table 2:
TABLE 2
Figure BDA0002248962390000051
Figure BDA0002248962390000061
The accelerated stability experiment shows that the appearance, the taste and the smell of the three samples, the embedding rate and the reconstitution property of the three samples are not changed after the three-month acceleration, the retention rate of the vitamin A is slightly reduced, but the product with the retention rate more than or equal to 90 percent after the three-month acceleration is generally considered to be qualified. It can be seen that the vitamin A microcapsule powder prepared by the process disclosed by the patent has excellent stability.
Example 6
Bioavailability was evaluated at the cellular level for samples 1-3 as follows:
TABLE 3
Name (R) Bioavailability of
Vitamin A raw material 5.63%
Sample 1 46.73%
Sample 2 45.60%
Sample 3 50.11%
The results show that the bioavailability of the vitamin A raw material is only 5.63 percent, and the bioavailability of the vitamin A microcapsule powder prepared by the formula and the process disclosed by the patent is 8-9 times of that of the raw material, so that the bioavailability is greatly improved.
Example 7
Referring to the formulation and process parameters of example 2, only sodium starch octenyl succinate and acacia gum were replaced by other wall materials of different types, and the effect of the combination of different wall materials and vitamin E polyethylene glycol succinate on the stability and bioavailability of the product was examined, with the following results:
TABLE 4
Figure BDA0002248962390000071
From the results, it can be seen that only sodium starch octenyl succinate and acacia gum act together with vitamin E polyethylene glycol succinate to obtain a product with high embedding rate, high stability and high bioavailability. While other wall material combinations do not have this effect.
Example 8
Referring to the formulation and process parameters of example 2, the vitamin E polyethylene glycol succinate alone was removed to yield a product with an entrapment rate of 98.1%, a 3-month accelerated retention rate of 93.2% at 40 ℃, and a cellular level bioavailability of 14.7%. Therefore, the combination of the vitamin E succinic acid polyethylene glycol ester and the wall material ensures the stability and bioavailability of the product, and is not indispensable.

Claims (6)

1. The preparation method of the vitamin A microcapsule preparation without the antioxidant comprises the following steps:
(1) preparing a raw material, wherein the raw material comprises the following components in parts by mass:
Figure FDA0003252196210000011
wherein the modified starch is selected from sodium starch octenylsuccinate and phosphorylated starch;
(2) sequentially dispersing modified starch and Arabic gum in water at 60-80 deg.C, stirring to dissolve completely, and cooling to 30-40 deg.C;
(3) adding an acidity regulator into the system obtained in the step (2), controlling the pH value to be 6-8, uniformly stirring, and adding glucose oxidase to obtain a water phase;
(4) adding vitamin E polyethylene glycol succinate into vitamin A, heating to melt at 60-80 deg.C, stirring, mixing, and cooling to 30-40 deg.C to obtain oil phase;
(5) slowly adding the oil phase into the water phase, and stirring at 30-40 ℃ until the oil phase and the water phase are uniformly mixed;
(6) shearing and emulsifying the mixture obtained in the step (5) for 0.5-1h, and then homogenizing for 2 times at 40-70MPa to obtain emulsion;
(7) and (3) spray drying the emulsion prepared in the step (6): the air inlet temperature is 80-210 ℃, and the air outlet temperature is 70-120 ℃; the product is sieved and then is uniformly mixed with an anticaking agent.
2. The method of claim 1, wherein the vitamin a is selected from the group consisting of vitamin a acetate, vitamin a palmitate, and mixtures thereof.
3. The method according to claim 1, wherein the acidity regulator is selected from one or more of sodium bicarbonate, sodium hydroxide, sodium carbonate, calcium hydroxide and potassium hydroxide.
4. The method of claim 3, wherein the acidity regulator is selected from the group consisting of sodium bicarbonate, calcium hydroxide, and sodium hydroxide.
5. The method of claim 1, wherein said anticaking agent is selected from the group consisting of silica, calcium silicate and tricalcium phosphate.
6. An antioxidant-free vitamin a microcapsule formulation prepared by the process of claim 1.
CN201911026965.7A 2019-10-26 2019-10-26 Vitamin A microcapsule preparation without antioxidant and preparation method thereof Active CN110693848B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911026965.7A CN110693848B (en) 2019-10-26 2019-10-26 Vitamin A microcapsule preparation without antioxidant and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911026965.7A CN110693848B (en) 2019-10-26 2019-10-26 Vitamin A microcapsule preparation without antioxidant and preparation method thereof

Publications (2)

Publication Number Publication Date
CN110693848A CN110693848A (en) 2020-01-17
CN110693848B true CN110693848B (en) 2021-12-14

Family

ID=69203622

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911026965.7A Active CN110693848B (en) 2019-10-26 2019-10-26 Vitamin A microcapsule preparation without antioxidant and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110693848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022061870A1 (en) * 2020-09-28 2022-03-31 厦门金达威生物科技有限公司 Vitamin k2 microcapsule, preparation method therefor, and application thereof in preparation of medicine for preventing and treating cardiovascular and cerebrovascular diseases
CN113598376B (en) * 2021-08-11 2023-11-21 郑州瑞普生物工程有限公司 Preparation method of folic acid microcapsule powder applied to copper ion-containing tablet products
CN113966816A (en) * 2021-10-25 2022-01-25 新疆农业大学 Preparation method of sea-buckthorn whole fruit powder capable of reducing caking rate and loss rate of bioactive substances
CN114209606B (en) * 2022-01-27 2023-05-23 广州巴泰新材料科技有限公司 Antioxidant organic silicone oil cosmetic composition and preparation process thereof
CN115336670A (en) * 2022-08-22 2022-11-15 广西靓牌畜牧科技有限责任公司 Vitamin water solution storage and quality guarantee method formula

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102198116A (en) * 2011-05-30 2011-09-28 何德海 Preparation method of vitamin A microcapsules
CN102224934A (en) * 2011-05-30 2011-10-26 何德海 Preparation method of vitamin A microcapsule nutrition enhancer for beverage
CN102716087A (en) * 2012-05-31 2012-10-10 浙江中同科技有限公司 Vitamin powder and preparation method thereof
CN106473132A (en) * 2015-09-02 2017-03-08 哈尔滨鑫红菊食品科技有限公司 A kind of employing starch alkenyl succinate sodium adds the nutraceutical processing technique of tert-butyl hydroquinone for primary raw material
WO2017063101A1 (en) * 2015-10-12 2017-04-20 浙江医药股份有限公司新昌制药厂 Method of preparing highly stable microcapsule powder or microparticles containing fat-soluble nutrient having increased double bonds
CN106579407A (en) * 2016-12-02 2017-04-26 南通励成生物工程有限公司 Preparation method of vitamin A microcapsule rice flour nutrition intensifier
CN107594597A (en) * 2017-07-31 2018-01-19 浙江新维普添加剂有限公司 A kind of fat soluble nutrient microcapsules and preparation method thereof
CN109452467A (en) * 2018-11-16 2019-03-12 厦门金达威维生素有限公司 A kind of type vitamin A microcapsules and its preparation method and application
CN109517080A (en) * 2018-11-06 2019-03-26 浙江大学 Starch octenyl succinate anhydride, fat soluble nutrient microcapsules and preparation method and application

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102198116A (en) * 2011-05-30 2011-09-28 何德海 Preparation method of vitamin A microcapsules
CN102224934A (en) * 2011-05-30 2011-10-26 何德海 Preparation method of vitamin A microcapsule nutrition enhancer for beverage
CN102716087A (en) * 2012-05-31 2012-10-10 浙江中同科技有限公司 Vitamin powder and preparation method thereof
CN106473132A (en) * 2015-09-02 2017-03-08 哈尔滨鑫红菊食品科技有限公司 A kind of employing starch alkenyl succinate sodium adds the nutraceutical processing technique of tert-butyl hydroquinone for primary raw material
WO2017063101A1 (en) * 2015-10-12 2017-04-20 浙江医药股份有限公司新昌制药厂 Method of preparing highly stable microcapsule powder or microparticles containing fat-soluble nutrient having increased double bonds
CN106579407A (en) * 2016-12-02 2017-04-26 南通励成生物工程有限公司 Preparation method of vitamin A microcapsule rice flour nutrition intensifier
CN107594597A (en) * 2017-07-31 2018-01-19 浙江新维普添加剂有限公司 A kind of fat soluble nutrient microcapsules and preparation method thereof
CN109517080A (en) * 2018-11-06 2019-03-26 浙江大学 Starch octenyl succinate anhydride, fat soluble nutrient microcapsules and preparation method and application
CN109452467A (en) * 2018-11-16 2019-03-12 厦门金达威维生素有限公司 A kind of type vitamin A microcapsules and its preparation method and application

Also Published As

Publication number Publication date
CN110693848A (en) 2020-01-17

Similar Documents

Publication Publication Date Title
CN110693848B (en) Vitamin A microcapsule preparation without antioxidant and preparation method thereof
JP7205835B2 (en) Fat-soluble nutrient microcapsules and method for producing the same
DK174663B1 (en) Stable mixture containing oxidation-sensitive compounds, process for their preparation and use of a combination of substances to stabilize oxidation-sensitive compounds
Wilson et al. Microencapsulation of vitamins
CN101669920A (en) Strong anti-oxidation DHA microcapsule and preparation method thereof
CN101902922B (en) Microcapsules comprising a fat-soluble active substance
CN111035015B (en) Non-water-soluble fat-soluble nutrient microcapsule and preparation method thereof
US2897119A (en) Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins
ZA200504129B (en) Homogeneous solid granules containing carotenoids.
CN109418541B (en) Preparation method of hydrophobic fat-soluble vitamin microcapsule
JP2010533667A (en) Tabletable lipophilic health ingredient formulation
CN101557720B (en) Active ingredient delivery system with an amorphous metal salt as carrier
JP2011177183A (en) Novel composition comprising carotenoid
CN112167615B (en) Hydrophobic fat-soluble nutrient microcapsule and preparation method thereof
CN108030063A (en) A kind of preparation method of the beta carotene microcapsules of high carrying capacity high bioavilability
CN105639647A (en) Vitamin and carotenoid powder as well as preparation method and application of vitamin and carotenoid powder
CN112741247A (en) Octenyl succinic acid starch ester and preparation method and application thereof
Tian et al. Preparation of starch-based functional food nano-microcapsule delivery system and its controlled release characteristics
CN112515088B (en) Water-dispersible lutein ester preparation and preparation method and application thereof
EP2217094A1 (en) Pulverous formulation of a fat-soluble active ingredient
CN115581303B (en) Vitamin solid, preparation method and application thereof
CN1764439B (en) Process for the production of cross-linked gelatin beadlets
JP2011505157A (en) Finely pulverized preparation of fat-soluble active ingredients
CN110547456A (en) carotenoid microcapsule taking sialic acid as coating material and preparation method and application thereof
JPS633769A (en) Production of microcapsule containing royal jelly

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant